Eli Lilly and NVIDIA Launch $1 Billion AI Lab to Accelerate Drug Discovery

Key Intelligence

• ■Eli Lilly and NVIDIA have announced a $1 billion partnership to establish a new AI co-innovation lab.
• ■The lab's primary goal is to significantly accelerate drug discovery, development, and manufacturing processes using artificial intelligence.
• ■This collaboration deepens ties between a leading pharmaceutical company and a pioneer in AI and accelerated computing.
• ■The initiative aims to revolutionize how new medicines are found and brought to market, enhancing efficiency and reducing timelines.